Palvella Therapeutics (PVLA) Return on Capital Employed Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | 9,287.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,287.00 |
| Sep 30, 2025 | 592.00 |
| Jun 30, 2025 | 1,559.00 |
| Mar 31, 2025 | 2,423.00 |
| Dec 31, 2024 | 1,456.00 |
| Sep 30, 2024 | 6,817.00 |
| Jun 30, 2024 | 3,687.00 |
| Mar 31, 2024 | 6,097.00 |
| Dec 31, 2023 | 29.00 |
| Sep 30, 2023 | -6,039.00 |
| Jun 30, 2023 | -6,265.00 |
| Mar 31, 2023 | -8,503.00 |
| Sep 30, 2022 | -1,284.00 |
| Jun 30, 2022 | -705.00 |
| Mar 31, 2022 | -1,612.00 |
| Dec 31, 2021 | -1,653.00 |
| Sep 30, 2021 | -3,838.00 |
| Jun 30, 2021 | -4,376.00 |
| Mar 31, 2021 | -2,626.00 |
| Dec 31, 2020 | -1,220.00 |
| Sep 30, 2020 | 1,984.00 |
| Jun 30, 2020 | 4,674.00 |
| Mar 31, 2020 | 5,310.00 |
| Dec 31, 2019 | 4,675.00 |
| Sep 30, 2019 | 802.00 |
| Jun 30, 2019 | -124.00 |
| Mar 31, 2019 | 1,427.00 |
| Dec 31, 2018 | 1,106.00 |
| Sep 30, 2018 | 4,604.00 |
| Jun 30, 2018 | 8,612.00 |
| Mar 31, 2018 | 3,507.00 |
| Sep 30, 2017 | 33.98 Mn |
| Jun 30, 2017 | 7.59 Mn |